PT  - JOURNAL ARTICLE
AU  - Linying Zhang
AU  - Lauren R. Richter
AU  - George Hripcsak
TI  - Assessing the Impact of Race on Glomerular Filtration Rate (GFR) Prediction
AID  - 10.1101/2021.10.26.21265423
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.10.26.21265423
4099  - http://medrxiv.org/content/early/2021/10/26/2021.10.26.21265423.short
4100  - http://medrxiv.org/content/early/2021/10/26/2021.10.26.21265423.full
AB  - Background The appropriate use and the implications of using variables that attempt to encode a patient’s race in clinical predictive algorithms remain unclear. The clinical algorithm for estimating glomerular filtration rate (GFR) adjusts for race, but the observed difference between Black and non-Black participants lacks biologically substantiated evidence. We investigated the impact of using a race variable on GFR prediction by race-stratified error analysis.Methods We implemented three predictive algorithms with varied amount of input information from an electronic health record database to estimate GFR. We compared the prediction error of the estimated GFR with and without the variable race between Black patients and White patients.Results The prediction error for patients coded as Black was higher than that for patients coded as White across all three algorithms. Removing race from the prediction algorithm did not lower the prediction error for patients coded as Black, neither did it decrease the difference in error between the two groups. The algorithm that included the most information with thousands of variables but excluding race produced the most accurate estimate for both groups and minimized the difference in performance between the two groups.Conclusion The prediction error for patients coded as Black was higher compared to those coded as White, regardless of inclusion of race as a variable. Using a large amount of information represented in electronic health record variables achieved a more accurate prediction of GFR and the least difference in prediction error across racial groups.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the National Library of Medicine grant R01-LM006910.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of Columbia University approved the study under protocol IRB-AAAF3162.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are not openly available due to patient privacy.